News
14d
News-Medical.Net on MSNLipid metabolism as a driver of therapy resistance in triple negative breast cancerLipid metabolism has emerged as a central player in the progression and therapy resistance of breast cancer, particularly the aggressive subtype known as triple-negative breast cancer (TNBC).
The ensemble of skeletal muscles can be considered the largest metabolic and endocrine organ of the human body. The more than ...
One such disease, nonalcoholic steatohepatitis (NASH), is characterized by dysregulated metabolism ... pathways. EMMs also have well-validated therapeutic precedence, e.g. omega-3 fatty acids in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results